Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

June 10, 2019

Study Completion Date

January 20, 2020

Conditions
HIV Infections
Interventions
DIAGNOSTIC_TEST

Blood and feces samples

"Blood samples are going to be taken by puncturing peripheral vein extraction with 10 ml of venous blood for later biweekly to monitor in person and therefore monitor immune status with biomarkers T lymphocyte subclass CD4 and viral load. A total of four blood samples will be taken at weeks 4, 8, 12 and 24 of recruitment.~A total of four feces samples are going to be required during the study, to evaluate the changes on the microbiota of the patient. 1 week before the patients start their HAART, the same day the patients initiate their HAART, 8 weeks after they started HAART and 24 weeks after HAART."

Trial Locations (1)

64460

Hospital Universitario José E. Gonzalez, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT04165200 - Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV | Biotech Hunter | Biotech Hunter